s20098 has been researched along with Migraine Disorders in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alamiri, B; Naguy, A | 1 |
| Turbina, LG | 1 |
| Campanella, D; De Bartolomeis, A; De Berardis, D; Di Giannantonio, M; Di Nicola, M; Fornaro, M; Iasevoli, F; Martinotti, G; Mazza, M; Olivieri, L; Perna, G; Rapini, G; Serroni, N; Srinivasan, V; Tomasetti, C; Valchera, A | 1 |
| Gromova, SA; Sergeev, AV; Tabeeva, GR | 1 |
| Levin, IaI | 1 |
1 review(s) available for s20098 and Migraine Disorders
| Article | Year |
|---|---|
Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression.
Topics: Acetamides; Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Fibromyalgia; Humans; Migraine Disorders; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Receptor, Serotonin, 5-HT2C; Schizophrenia; Sleep Wake Disorders | 2015 |
1 trial(s) available for s20098 and Migraine Disorders
| Article | Year |
|---|---|
[Possibilities of preventive treatment of migraine with the MT1- and MT2 agonist and 5-HT2с receptor antagonist agomelatin (valdoxan)].
Topics: Acetamides; Adult; Female; Humans; Male; Middle Aged; Migraine Disorders; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Serotonin 5-HT2 Receptor Antagonists; Treatment Outcome; Young Adult | 2011 |
3 other study(ies) available for s20098 and Migraine Disorders
| Article | Year |
|---|---|
Successful agomelatine monotherapy for an adolescent with attention deficit hyperactivity disorder and comorbid migraine.
Topics: Acetamides; Adolescent; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Comorbidity; Humans; Migraine Disorders; Naphthalenes | 2022 |
[The use of agomelatine for the preventive treatment of migraine].
Topics: Acetamides; Adult; Female; Humans; Hypnotics and Sedatives; Melatonin; Middle Aged; Migraine Disorders; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Treatment Outcome | 2014 |
[Clinical experience in using agomelatin (valdoxan) in the neurological practice].
Topics: Acetamides; Aged; Benzodiazepines; Depression; Female; Fibromyalgia; Humans; Hypnotics and Sedatives; Male; Middle Aged; Migraine Disorders; Sleep Initiation and Maintenance Disorders; Stroke; Withholding Treatment | 2011 |